(NASDAQ: FLGC) Flora Growth's forecast annual revenue growth rate of -1.08% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 3,543.73%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 1,466.34%.
Flora Growth's revenue in 2025 is $49,656,000.On average, 4 Wall Street analysts forecast FLGC's revenue for 2025 to be $36,412,223, with the lowest FLGC revenue forecast at $33,167,723, and the highest FLGC revenue forecast at $39,429,896.
In 2026, FLGC is forecast to generate $36,460,405 in revenue, with the lowest revenue forecast at $29,403,600 and the highest revenue forecast at $43,560,944.